BioSpace News Archive

Anchiano Therapeutics Ltd. announced that Mr. Stan Polovets has been elected chairman of its board of directors.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Jefferies Virtual Healthcare Conference, which is being held June 2-4, 2020.

Brilacidin showed a dose-dependent inhibitory response in a human kidney cell line expressing hACE2

Quotient Limited, a commercial-stage diagnostics company, announced that financial results for its fiscal fourth quarter and full year ended March 31, 2020 will be released before market open on Tuesday, June 9, 2020.

First U.S. study to feature double-blinded, controlled, randomized trial design with safety and oxygenation endpoints

Menlo Therapeutics Inc., a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, announced that David Domzalski, Chief Executive Officer, will provide a corporate overview at the Jefferies Virtual Healthcare Conference, being held June 2-4, 2020.

Caladrius Biosciences, Inc. announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 2,084,850 shares of its common stock, at a purchase price of $2.0625 per share, in a registered direct offering priced at-the-market under Nasdaq rules.

Lewis and Kaysen each bring decades of global industry expertise and senior leadership to the urology wireless neurostimulation venture

AnPac Bio-Medical Science Co., Ltd. announced that another new US patent titled “Apparatus for Improved Disease Detection” was granted to the Company by the United States Patent and Trademark Office on May 20, 2020, which is the second AnPac Bio patent granted this month, and the third in 2020.

Allena Pharmaceuticals, Inc. announced that Louis Brenner, M.D., Allena’s President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 2:30 p.m.